Technology

Biodesix Adds AI-Powered Imaging Test To Expand Lung Cancer Risk Screening

Oct 19, 2026 · 06:03 AM ET· updated 56m ago

Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostics solutions company, today announced the addition of Digital Diagnostics to its Lung Diagnostics strategy, establishing the foundation for a multimodal diagnostic

Why It Matters

Biodesix added a new AI tool to find lung cancer earlier. This shows the company is building more ways to help doctors, which could attract more customers.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

BDSX23.66

-1.05 (-4.25%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.